Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people who are obese and overweight. The company offers the Obalon balloon system designed to provide weight loss in obese patients. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [06/12/2019 10:30 PDT] Obalon Therapeutics, Inc. (NASDAQ:OBLN), Down By 100.00% ($1.05) From $1.050 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [06/06/2019 07:30 PDT] OBLN Expected to Trade Down After Bearish Patterns Develop
• [06/05/2019 11:46 PDT] Obalon Therapeutics, Inc. (NASDAQ:OBLN), Down By 100.00% ($1.29) From $1.290 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [06/04/2019 07:49 PDT] OBLN Expected to Trade Down After Bearish Patterns Develop
• [05/29/2019 10:29 PDT] Obalon Therapeutics, Inc. (NASDAQ:OBLN), Up By 100.00% ($0.68) From $0.680 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/24/2019 07:20 PDT] OBLN Expected to Trade Up After Bullish Patterns Develop